For: | Li YY, Shi ZM, Yu XY, Feng P, Wang XJ. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells. World J Gastroenterol 2016; 22(25): 5769-5779 [PMID: 27433090 DOI: 10.3748/wjg.v22.i25.5769] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i25/5769.htm |
Number | Citing Articles |
1 |
Cheng‑Fang Yang, Yu‑Juan Zhong, Zuheng Ma, Li Li, Lin Shi, Li Chen, Chen Li, Dan Wu, Qi Chen, Yong‑Wen Li. NOX4/ROS mediate ethanol‑induced apoptosis via MAPK signal pathway in L‑02 cells. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3390
|
2 |
Jun Fang, Mei Tang. Exercise improves high fat diet-impaired vascular function. Biomedical Reports 2017; 7(4): 337 doi: 10.3892/br.2017.972
|
3 |
Pingli Liu, Li Shi, Xiaomin Cang, Jieru Huang, Xue Wu, Jin Yan, Ling Chen, Shiwei Cui, Xinhua Ye. CtBP2 ameliorates palmitate-induced insulin resistance in HepG2 cells through ROS mediated JNK pathway. General and Comparative Endocrinology 2017; 247: 66 doi: 10.1016/j.ygcen.2017.01.018
|
4 |
Na Li, Lin Yin, Xi Chen, Jiamin Shang, Meidai Liang, Li Gao, Guifen Qiang, Jie Xia, Guanhua Du, Xiuying Yang. Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor. Molecules 2022; 27(24): 8692 doi: 10.3390/molecules27248692
|
5 |
Jae Eun Park, Ji Sook Han. HM-chromanone isolated from Portulaca oleracea L. alleviates insulin resistance and inhibits gluconeogenesis by regulating palmitate-induced activation of ROS/JNK in HepG2 cells. Toxicology Research 2023; 12(4): 648 doi: 10.1093/toxres/tfad055
|
6 |
Ying-ying Li, Zheng-ming Shi, Xiao-tong Yu, Ping Feng, Xue-Jiang Wang. The effects of urotensin II on migration and invasion are mediated by NADPH oxidase-derived reactive oxygen species through the c-Jun N-terminal kinase pathway in human hepatoma cells. Peptides 2017; 88: 106 doi: 10.1016/j.peptides.2016.12.005
|
7 |
D. A. B. Rex, G. P. Suchitha, Akhina Palollathil, Anagha Kanichery, T. S. Keshava Prasad, Shobha Dagamajalu. The network map of urotensin-II mediated signaling pathway in physiological and pathological conditions. Journal of Cell Communication and Signaling 2022; 16(4): 601 doi: 10.1007/s12079-022-00672-4
|
8 |
HAYRUNNISA BEKİS BOZKURT, MUHAMMED YAYLA, DAMLA BINNETOGLU, MULTEHAN EVRAN. The Association of Passive Smoking and Serum Urotensin-II Levels in Children. Anais da Academia Brasileira de Ciências 2022; 94(2) doi: 10.1590/0001-3765202220201488
|
9 |
Mehmet Calan, Tugba Arkan, Tuncay Kume, Fırat Bayraktar. The relationship between urotensin II and insulin resistance in women with gestational diabetes mellitus. Hormones 2019; 18(1): 91 doi: 10.1007/s42000-018-0084-7
|
10 |
Xi Chen, Lin Yin, Wei-hua Jia, Nuo-qi Wang, Chun-yang Xu, Bi-yu Hou, Na Li, Li Zhang, Gui-fen Qiang, Xiu-ying Yang, Guan-hua Du. Chronic Urotensin-II Administration Improves Whole-Body Glucose Tolerance in High-Fat Diet-Fed Mice. Frontiers in Endocrinology 2019; 10 doi: 10.3389/fendo.2019.00453
|
11 |
M. Demirpence, A. Guler, H. Yilmaz, A. Sayin, Y. Pekcevik, H. Turkon, A. Colak, E. M. Ari, B. Aslanipour, G. U. Kocabas, M. Calan. Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly?. Journal of Endocrinological Investigation 2019; 42(2): 207 doi: 10.1007/s40618-018-0905-1
|
12 |
Shui-lin Sun, Liang-ming Liu. Urotensin II: an inflammatory cytokine. Journal of Endocrinology 2019; 240(3): R107 doi: 10.1530/JOE-18-0505
|